Lukas Leu
Portfolio ManagerMale0.0Global Dominance: 0.00%
Lukas Leu is a portfolio manager at Bellevue, a healthcare investment specialist, known for his insights into the pharmaceutical industry. In a recent context, he criticized Novo Nordisk's communication regarding their clinical study results for the obesity medication CagriSema, highlighting the company's failure to meet expectations and provide transparent information.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Novo shareholder Lukas Leu, a portfolio manager at ATG Healthcare, said Novo’s cost-cutting measures fell short of reassuring investors.
Novo Nordisk cuts 9,000 jobs as it fends off competition in weight-loss drugsThe Globe and Mail·
Canada· 2025-09-10
Canada· 2025-09-10
Lukas Leu criticized Novo Nordisk's communication regarding the study results.
Vom Börsenstar zum Sorgenkind – findet Novo Nordisk zurück in die Spur?Neue Zürcher Zeitung·
Switzerland· 2025-08-07
Switzerland· 2025-08-07
